dc.contributor.author | Lampertico, Pietro | |
dc.contributor.author | Colombo, Massimo | |
dc.contributor.author | Janssen, Harry L. | |
dc.contributor.author | Tabak, Fehmi | |
dc.contributor.author | Cakaloglu, Yilmaz | |
dc.contributor.author | Rijckborst, Vincent | |
dc.contributor.author | Hansen, Bettina E. | |
dc.contributor.author | Ferenci, Peter | |
dc.contributor.author | Brunetto, Maurizio R. | |
dc.contributor.author | Lanza, Alfonso G. | |
dc.contributor.author | Messina, Vincenzo | |
dc.contributor.author | Iannacone, Claudio | |
dc.contributor.author | Massetto, Benedetto | |
dc.contributor.author | Martins, Eduardo B. | |
dc.date.accessioned | 2021-03-06T07:52:39Z | |
dc.date.available | 2021-03-06T07:52:39Z | |
dc.identifier.citation | Rijckborst V., Hansen B. E. , Ferenci P., Brunetto M. R. , Tabak F., Cakaloglu Y., Lanza A. G. , Messina V., Iannacone C., Massetto B., et al., "EARLY ON-TREATMENT HBSAG AND HBV DNA LEVELS IDENTIFY HBEAG-NEGATIVE PATIENTS NOT RESPONDING TO 48 OR 96 WEEKS OF PEGINTERFERON ALFA-2A THERAPY", 61st Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Massachusetts, Amerika Birleşik Devletleri, 29 Ekim - 02 Kasım 2010, cilt.52 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_de4aa4b1-83ce-4124-a03b-eb74622c2739 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/146451 | |
dc.language.iso | eng | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | Gastroenteroloji-(Hepatoloji) | |
dc.subject | GASTROENTEROLOJİ VE HEPATOLOJİ | |
dc.subject | Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.title | EARLY ON-TREATMENT HBSAG AND HBV DNA LEVELS IDENTIFY HBEAG-NEGATIVE PATIENTS NOT RESPONDING TO 48 OR 96 WEEKS OF PEGINTERFERON ALFA-2A THERAPY | |
dc.type | Bildiri | |
dc.contributor.department | Erasmus University Rotterdam , , | |
dc.identifier.volume | 52 | |
dc.contributor.firstauthorID | 137506 | |